| Product Code: ETC8274929 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Cell and Gene Therapy Manufacturing Services Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Cell and Gene Therapy Manufacturing Services Market - Industry Life Cycle |
3.4 Mexico Cell and Gene Therapy Manufacturing Services Market - Porter's Five Forces |
3.5 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mexico Cell and Gene Therapy Manufacturing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development activities related to cell and gene therapy in Mexico |
4.2.2 Growing prevalence of chronic diseases driving the demand for advanced treatment options like cell and gene therapy |
4.2.3 Favorable regulatory environment supporting the growth of cell and gene therapy manufacturing services in Mexico |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy manufacturing services limiting market penetration |
4.3.2 Lack of skilled workforce and infrastructure for manufacturing cell and gene therapy products |
4.3.3 Stringent regulatory requirements for manufacturing cell and gene therapy products leading to delays in market entry |
5 Mexico Cell and Gene Therapy Manufacturing Services Market Trends |
6 Mexico Cell and Gene Therapy Manufacturing Services Market, By Types |
6.1 Mexico Cell and Gene Therapy Manufacturing Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 Mexico Cell and Gene Therapy Manufacturing Services Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Oncology Diseases, 2021- 2031F |
6.2.3 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Orthopedic Diseases, 2021- 2031F |
6.2.5 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Ophthalmology Diseases, 2021- 2031F |
6.2.6 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Central Nervous System Disorder, 2021- 2031F |
6.2.7 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 Mexico Cell and Gene Therapy Manufacturing Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Clinical Manufacturing, 2021- 2031F |
6.3.3 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Commercial Manufacturing, 2021- 2031F |
6.4 Mexico Cell and Gene Therapy Manufacturing Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.4 Mexico Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Cell and Gene Therapy Manufacturing Services Market Import-Export Trade Statistics |
7.1 Mexico Cell and Gene Therapy Manufacturing Services Market Export to Major Countries |
7.2 Mexico Cell and Gene Therapy Manufacturing Services Market Imports from Major Countries |
8 Mexico Cell and Gene Therapy Manufacturing Services Market Key Performance Indicators |
8.1 Number of clinical trials utilizing cell and gene therapy products in Mexico |
8.2 Adoption rate of cell and gene therapy manufacturing services by pharmaceutical and biotech companies in Mexico |
8.3 Investment trends in the cell and gene therapy manufacturing sector in Mexico |
9 Mexico Cell and Gene Therapy Manufacturing Services Market - Opportunity Assessment |
9.1 Mexico Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mexico Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Mexico Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mexico Cell and Gene Therapy Manufacturing Services Market - Competitive Landscape |
10.1 Mexico Cell and Gene Therapy Manufacturing Services Market Revenue Share, By Companies, 2024 |
10.2 Mexico Cell and Gene Therapy Manufacturing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here